What is OSELTAMAVIR PHOSPHATE used for?

OSELTAMAVIR PHOSPHATE (brand name oseltamavir phosphate) is a Electrolyte / Mineral indicated for 1 INDICATIONS & USAGE Oseltamivir phosphate capsules USP, is an influenza neuraminidase inhibitor (NAI) indicated for: • Treatment of acute.

What are the most common side effects of OSELTAMAVIR PHOSPHATE?

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for OSELTAMAVIR PHOSPHATE. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Is OSELTAMAVIR PHOSPHATE the same as oseltamavir phosphate?

oseltamavir phosphate is a brand name for OSELTAMAVIR PHOSPHATE. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

OSELTAMAVIR PHOSPHATE

Q: How does OSELTAMAVIR PHOSPHATE work?

OSELTAMAVIR PHOSPHATE works through the following mechanism: 12.1 Mechanism of Action Oseltamivir is an antiviral drug with activity against influenza virus [see Microbiology ( 12.4 )]..

Electrolyte / Mineral

Brand names: oseltamavir phosphate

Pregnancy: Category COral

Mechanism of Action

12.1 Mechanism of Action Oseltamivir is an antiviral drug with activity against influenza virus [see Microbiology ( 12.4 )].

Indications

1 INDICATIONS & USAGE Oseltamivir phosphate capsules USP

is an influenza neuraminidase inhibitor (NAI) indicated for: • Treatment of acute

Contraindications

• Stevens-Johnson Syndrome
• and erythema multiforme [see Warnings and Precautions ( 5.1 )] . Patients with known serious hypersensitivity to oseltamivir or any of the components of oseltamivir phosphate capsules ( 4 )

FDA Warnings

5 WARNINGS AND PRECAUTIONS • Serious skin/hypersensitivity reactions such as Stevens-Johnson Syndrome, toxic epidermal necrolysis and erythema multiforme: Discontinue oseltamivir phosphate capsules and initiate appropriate treatment if allergic-like reactions occur or are suspected
1 ) • Neuropsychiatric events: Patients with influenza, including those receiving oseltamivir phosphate capsules, particularly pediatric patients, may be at an increased risk of confusion or abnormal behavior early in their illness
1 Serious Skin/Hypersensitivity Reactions Cases of anaphylaxis and serious skin reactions including toxic epidermal necrolysis, Stevens-Johnson Syndrome, and erythema multiforme have been reported in postmarketing experience with oseltamivir phosphate capsules
The use of oseltamivir phosphate capsules is contraindicated in patients with known serious hypersensitivity to oseltamivir phosphate [see Contraindications ( 4 ) and Adverse Reactions ( 6

Known Side Effects

0 documented side effects by frequency

No structured side effect data available.

Community Discussions

No community discussions found for OSELTAMAVIR PHOSPHATE yet.

Primary sources

Every figure on this page links back to its primary source. See data sources for full provenance.

DailyMed FDA label search → OSELTAMAVIR PHOSPHATE openFDA label JSON → OSELTAMAVIR PHOSPHATE FAERS adverse-event reports → OSELTAMAVIR PHOSPHATE ClinicalTrials.gov → completed Phase 2+ trials of OSELTAMAVIR PHOSPHATE

Compare With

0 available comparisons

No comparisons yet.

Formulations

Dosage Forms

Tablet

Route

Oral